Karl Peter’s fundamental contribution to the structural organization of the kidney.
Our authors: Šebeková Katarína
All authors: Heidland A, Klassen A, Fazeli G, Sebekova K, Bahner U

Journal of Nephrology, 24 (17): 51-57, 2011

https://www.ncbi.nlm.nih.gov/pubmed/21614779

The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats.
Our authors: Celec Peter, Hodosy Július, Šebeková Katarína, Boor Peter
All authors: Boor P, Celec P, Martin IV, Villa L, Hodosy J, Klenovicsova K, Esposito C, Schafer S, Albrecht-Kupper B, Ostendorf T, Heidland A, Sebekova K

Kidney International, 80 (11): 1182-1197, 2011

http://www.sciencedirect.com/science/article/pii/S0085253815549703

Association of sVAP-1, sRAGE, and CML with lactation-induced insulin sensitivity in young non-diabetic healthy women.
Our authors: Šebeková Katarína
All authors: Klenovicsova K, Krivosikova Z, Gajdos M, Sebekova K

Clinica Chimica Acta, 412 (19-20): 1842-1847, 2011

http://www.sciencedirect.com/science/article/pii/S0009898111003524

[An association between microalbuminuria and obesity in healthy adolescents – preliminary results from the “Respect for Health” study].
Our authors: Šebeková Katarína
All authors: Sebekova K, Kollarova R, Stecova A, Poticny V, Gerova Z

Vnitrni Lekarstvi, ;58 (7-8): 544-552, 2012
http://www.ncbi.nlm.nih.gov/pubmed/23067168

Advanced glycation end products in myocardial reperfusion injury.
Our authors: Celec Peter, Hodosy Július, Šebeková Katarína
All authors: Celec P, Hodosy J, Jani P, Janega P, Kudela M, Kalousova M, Holzerova J, Parrak V, Halcak L, Zima T, Braun M, Pechan I, Murin J, Sebekova K

Heart and Vessels, 27 (2): 208-215, 2012
http://link.springer.com/article/10.1007%2Fs00380-011-0147-z?LI=true

The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats.
Our authors: Celec Peter, Hodosy Július, Šebeková Katarína, Gardlík Roman
All authors: Celec P, Hodosy J, Gardlik R, Behuliak M, Palffy R, Pribula M, Jani P, Turna J, Sebekova K

Human Gene Therapy, 23 (2): 158-166, 2012
http://online.liebertpub.com/doi/abs/10.1089/hum.2011.030

Advanced oxidation protein products and advanced glycation end products in children and adolescents with chronic renal insufficiency.
Our authors: Šebeková Katarína
All authors: Sebekova K, Klenovicsova K, Ferenczova J, Hedvig J, Podracka L, Heidland A

Journal of Renal Nutrition, 22 (1): 143-148, 2012
http://www.sciencedirect.com/science/article/pii/S1051227611002123

Behaviour and hormonal status in healthy rats on a diet rich in Maillard reaction products with or without solvent extractable aroma compounds.
Our authors: Celec Peter, Šebeková Katarína, Boor Peter
All authors: Sebekova K, Klenovics KS, Boor P, Celec P, Behuliak M, Schieberle P, Heidland A, Palkovits M, Somoza V

Physiology & Behavior, 105 (3): 693-701, 2012
http://www.sciencedirect.com/science/article/pii/S0031938411004811

Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine.
Our authors: Šebeková Katarína
All authors: Palkovits M, Sebekova K, Klenovics KS, Kebis A, Fazeli G, Bahner U, Heidland A

PLoS One, 8 (6): 6543, 2013
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688530/pdf/pone.0066543.pdf

Neuromuscular electrostimulation techniques: historical aspects and current possibilities in treatment of pain and muscle waisting.
Our authors: Šebeková Katarína
All authors: Heidland A, Fazeli G, Klassen A, Sebekova K, Hennemann H, Bahner U, Di Iorio B

Clinical Nephrology, 79 (13): 12-23, 2013
https://www.dustri.com/nc/article-response-page.html?artId=10232&doi=

Sex differences of oxidative stress markers in young healthy subjects are marker-specific in plasma but not in saliva.
Our authors: Celec Peter, Hodosy Július, Šebeková Katarína, Tóthová Ľubomíra
All authors: Tothova L, Ostatnikova D, Sebekova K, Celec P, Hodosy J

Annals of Human Biology, 40 (2): 175-180, 2013
http://informahealthcare.com/doi/pdf/10.3109/03014460.2012.754495

Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus.
Our authors: Šebeková Katarína
All authors: Bartakova V, Kollarova R, Kuricova K, Sebekova K, Belobradkova J, Kankova K

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, 16 (1):70-75, 2016

http://biomed.papers.upol.cz/pdfs/bio/2016/01/08.pdf

Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.
Our authors: Šebeková Katarína
All authors: Gurecka R, Koborova I, Csongova M, Sebek J, Sebekova K

Glycoconjugate journal, 33(4):599-606, 2016

http://download.springer.com/static/pdf/65/art%253A10.1007%252Fs10719-016-9696-9.pdf?originUrl=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs10719-016-9696-9&token2=exp=1490955914~acl=%2Fstatic%2Fpdf%2F65%2Fart%25253A10.1007%25252Fs10719-016-9696-9.pdf%3ForiginUrl%3Dhttp%253A%252F%252Flink.springer.com%252Farticle%252F10.1007%252Fs10719-016-9696-9*~hmac=06161c88f73d4a9a55fca34f92d2a5b37ad2bcbd487003015505b69366274dca

Markery oxidacneho a karboniloveho stresu v plazme a slinachu chorych s akutnou intermitentnou porfyriou.
Our authors: Šebeková Katarína
All authors: Mydlik M, Derzsiova I, Koborova I, Sebekova K

Vnitrni lekarstvi, 62(12suppl. 6):6525-6529, 2016

http://www.prolekare.cz/pdf?id=60093

A pilot study of a genetic CJD risk factor (E200K) in the general Slovak population.
Our authors: Šebeková Katarína
All authors: Mitrova E, Kosorinova D, Gajdos M, Sebekova K, Tomeckova I
European Journal of Epidemiology, 29 (8): 595-597, 2014
http://link.springer.com/article/10.1007%2Fs10654-014-9937-9
Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? – In the search for minimizing of the adverse effects of PAMAM administration.
Our authors: Šebeková Katarína
All authors: Labieniec-Watala M, Przygodzki T, Sebekova K, Watala C

International Journal of Pharmaceutics, 464 (1-2): 152-167, 2014
http://ac.els-cdn.com/S0378517314000210/1-s2.0-S0378517314000210-main.pdf?_tid=6d2c905a-fd1b-11e3-8982-00000aacb35d&acdnat=1403778179_ff9faa3db547055a449a814804804631

Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population.
Our authors: Celec Peter, Hodosy Július, Šebeková Katarína
All authors: Simon Klenovics K, Kollarova R, Hodosy J, Celec P, Sebekova K

Diabetic Medicine, 31 (5): 581-585, 2014
http://onlinelibrary.wiley.com/doi/10.1111/dme.12326/pdf

Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultrasmall superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats.
Our authors: Celec Peter, Hodosy Július, Šebeková Katarína, Boor Peter
All authors: Sebekova K, Dusinska M, Simon Klenovics K, Kollarova R, Boor P, Kebis A, Staruchova M, Vlkova B, Celec P, Hodosy J, Baciak L, Tuskova R, Beno M, Tulinska J, Pribojova J, Bilanicova D, Pojana G, Marcomini A, Volkovova K

Nanotoxicology, 8: 142-157, 2014
http://informahealthcare.com/doi/abs/10.3109/17435390.2012.763147